Basic Information
Basic information for PART1-207-41aa
Peptide Name PART1-207-41aa
Genome Position chr5:60491303-60491425[+]
Species Human
Peptide Sequence MFLVQITKHFIWINGPQNLLLAHGGNFLLYFVVVVVLVVIV
Peptide Length 41
Unique No (PART1-203-41aa)
Grand Average of Hydropathicity 1.5561
Relative Molecular Mass 5386.36
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000152931;PART1
Transcript ID/Name ENST00000667192;PART1-207
Transcript Length 2831
Coding Ability 0.4214
DNA Sequence Corresponding to Peptide ATGTTCTTGGTTCAGATAACAAAACACTTTATCTGGATAAATGGACCTCAAAATTTGCTCTTGGCACATGGGGGAAATTTTTTGTTGTATTTTGTTGTTGTTGTTGTTCTTGTTGTTATTGTT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :